As a pharmaceutical manufacturer, ensuring the highest safety and quality standards is non-negotiable, especially when it comes to pyrogen testing. Traditional methods such as the rabbit pyrogen test are becoming obsolete, and animal testing is no longer a viable or ethical option under current regulatory expectations.
We’re proud to be part of the solution with the launch of a next generation monocyte activation test (MAT) – the NAT-MAT®. It combines the established MAT with modern digital PCR (dPCR) technology and analyses the gene expression the two cytokines (IL-1β and TNFα). The NAT-MAT® enables animal-free, highly accurate and reliable detection of endotoxin and non-endotoxin pyrogens according to Ph. Eur. 2.6.30.
Why does this matter to you?
The NAT-MAT® not only meets stringent regulatory requirements but also delivers high reproducibility and scalability — ideal for modern pharmaceutical production environments.
Read our latest blog post to explore the science behind the NAT-MAT®:
|
